Months after developing one of the nation’s first saliva-based coronavirus tests, researchers at Rutgers University are closing in on their next breakthrough: A saliva test for both COVID-19 and the flu. The research is being conducted at RUCDR Infinite Biologics — a unit of Rutgers’ Human Genetics Institute of New Jersey — the same lab that gained federal approval in April for a coronavirus saliva test. The test allows people to collect their own samples at home and send them to be processed. Andrew Brooks, chief operating officer and director of technology development at RUCDR, said the lab hopes to have a test approved by the fall. And just in time for flu season. To read the full story.
- Beyond the Opioid Epidemic: Scientist Seeks to Develop non-Addictive Treatment for Pain.
- Avoiding a “Tripledemic” This Winter.
- Overdose deaths from fentanyl combined with stimulants increased 50-fold since 2010.
- Sober socializing, a growing movement in New Jersey.
- Register for the NJ ACTS Biostatisics, Epidemiolgy, Research Design Workshop Series on 10/19 for